Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
6.64
+0.13 (2.00%)
At close: May 17, 2024, 4:00 PM
6.60
-0.04 (-0.60%)
After-hours: May 17, 2024, 6:14 PM EDT
Relay Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Relay Therapeutics stock have an average target of 22.2, with a low estimate of 15 and a high estimate of 30. The average target predicts an increase of 234.34% from the current stock price of 6.64.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RLAY stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Buy Upgrades $15 | Hold → Buy | Upgrades | $15 | +125.90% | May 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $24 | Buy | Reiterates | $24 | +261.45% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $33 → $25 | Buy | Reiterates | $33 → $25 | +276.51% | May 6, 2024 |
| Stifel | Stifel | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +351.81% | Feb 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $17 | Strong Buy | Maintains | $19 → $17 | +156.02% | Dec 11, 2023 |
Financial Forecast
Revenue This Year
204.00K
from 25.55M
Decreased by -99.20%
Revenue Next Year
10.86M
from 204.00K
Increased by 5,223.53%
EPS This Year
-2.97
from -2.79
EPS Next Year
-2.84
from -2.97
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.1M | 69.9M | 17.7M | 97.7M | 424.3M |
| Avg | 204,000 | 10.9M | 4.3M | 55.5M | 194.1M |
| Low | n/a | n/a | n/a | 10.8M | 63.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -95.9% | 34,143.6% | 63.4% | 2,165.7% | 664.3% |
| Avg | -99.2% | 5,223.5% | -60.3% | 1,188.2% | 249.6% |
| Low | - | - | - | 150.1% | 14.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.56 | -2.43 | -1.86 | -1.61 | -0.08 |
| Avg | -2.97 | -2.84 | -2.55 | -2.35 | -1.44 |
| Low | -3.26 | -3.05 | -2.86 | -3.16 | -2.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.